New Activist Brancous Launches Proxy Fight for Braemar Board After Al Shams Settles
BHR is trading near its 52-week low of $1.18 (11% above the low).
Summary
Brancous LP1, a 0.9% stockholder, launched a proxy contest to elect five independent directors at Braemar's December 21 annual meeting, days after the Company settled with activist Al Shams. The Company has rejected Brancous's nominations as invalid, and Brancous plans to seek court relief.
Key Events · Corporate Governance and Compliance · BHR
-
Brancous Launches Proxy Contest
Brancous LP1, holding 650,010 shares (0.9%), filed a preliminary proxy statement to elect five independent directors — Oliver Corlette, Ronald Davies, Andrew Fleiss, Michael Litwin, and Alejandro Malbran — at the December 21, 2026 annual meeting.
-
Company Rejects Nominations as Invalid
On October 5, 2026, Braemar's counsel asserted Brancous's notice of nomination is deficient under the Bylaws, including grounds that it was delivered by e-mail rather than physically. Brancous disputes this and intends to seek court relief to ensure its nominees appear on the ballot.
-
Al Shams Settlement Removes Largest Shareholder's Vote
On October 6, 2026, Braemar settled with Al Shams, its largest stockholder (9.5%), for $40 million. Al Shams withdrew its own five-director slate and agreed to vote with the Board, leaving Brancous as the only remaining activist challenger.
-
Prior Acquisition Proposals Disclosed
Brancous disclosed it made two non-binding proposals in November and December 2025 to acquire all outstanding common stock for $4.00 per share in cash, both rejected by the Board and since withdrawn.
Analysis · BHR · Real Estate & Construction
Brancous LP1, a 0.9% stockholder, has filed a preliminary proxy statement to elect five independent directors at Braemar's December 21 annual meeting. This comes just eight days after the Company settled with its largest shareholder, Al Shams, for $40 million — a deal that removed Al Shams's competing slate and locked its 9.5% stake into voting with the Board. Brancous argues the current Board, which oversaw the $480 million Ashford termination fee, should not choose its own successors. The Company has already rejected Brancous's nominations as invalid, setting up a potential court fight over whether stockholders can even vote for these candidates. With the stock down roughly 40% over the past year and the Company selling off its hotel portfolio to pay Ashford, this contest goes to the heart of who controls the remaining asset-sale proceeds.
How filings like this one have moved
In the 30 days to Oct 29, 2026, 39.1% of the 988 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.56%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BHR was trading at $1.31 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $89.6M. The 52-week trading range was $1.18 to $3.19. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.